Aparna Bahuguna - Publications

Affiliations: 
2015-2020 University of Delhi 

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Danishuddin, Kumar V, Parate S, Bahuguna A, Lee G, Kim MO, Lee KW. Development of Machine Learning Models for Accurately Predicting and Ranking the Activity of Lead Molecules to Inhibit PRC2 Dependent Cancer. Pharmaceuticals (Basel, Switzerland). 14. PMID 34358125 DOI: 10.3390/ph14070699  0.342
2021 Bahuguna A, Rawat S, Rawat DS. QcrB in Mycobacterium tuberculosis: The new drug target of antitubercular agents. Medicinal Research Reviews. PMID 33400275 DOI: 10.1002/med.21779  0.646
2020 Bahuguna A, Bharadwaj S, Chauhan AK, Kang SC. Inhibitory insights of strawberry (Fragaria × ananassa var. Seolhyang) root extract on tyrosinase activity using computational and in vitro analysis. International Journal of Biological Macromolecules. PMID 33470201 DOI: 10.1016/j.ijbiomac.2020.10.135  0.409
2020 Bahuguna A, Bharatam PV, Rawat DS. 3D QSAR studies on amphiphilic indoles for antimycobacterial activity. Journal of Biochemical and Molecular Toxicology. e22675. PMID 33347664 DOI: 10.1002/jbt.22675  0.69
2020 Bahuguna A, Singh A, Kumar P, Dhasmana D, Krishnan V, Garg N. Bisindolemethane derivatives as highly potent anticancer agents: Synthesis, medicinal activity evaluation, cell-based compound discovery, and computational target predictions. Computers in Biology and Medicine. 116: 103574. PMID 31999555 DOI: 10.1016/j.compbiomed.2019.103574  0.384
2019 Bahuguna A, Rawat DS. An overview of new antitubercular drugs, drug candidates, and their targets. Medicinal Research Reviews. PMID 31254295 DOI: 10.1002/Med.21602  0.557
2018 Maurya SS, Bahuguna A, Khan SI, Kumar D, Kholiya R, Rawat DS. N-Substituted aminoquinoline-pyrimidine hybrids: Synthesis, in vitro antimalarial activity evaluation and docking studies. European Journal of Medicinal Chemistry. 162: 277-289. PMID 30448417 DOI: 10.1016/J.Ejmech.2018.11.021  0.597
2017 Kholiya R, Khan SI, Bahuguna A, Tripathi M, Rawat DS. N-Piperonyl substitution on aminoquinoline-pyrimidine hybrids: Effect on the antiplasmodial potency. European Journal of Medicinal Chemistry. 131: 126-140. PMID 28315598 DOI: 10.1016/J.Ejmech.2017.03.007  0.693
2017 Maurya SS, Khan SI, Bahuguna A, Kumar D, Rawat DS. Synthesis, antimalarial activity, heme binding and docking studies of N-substituted 4-aminoquinoline-pyrimidine molecular hybrids. European Journal of Medicinal Chemistry. 129: 175-185. PMID 28222317 DOI: 10.1016/J.Ejmech.2017.02.024  0.742
Show low-probability matches.